EUVIMEDEUVIMED entdecken
Leitlinie

Belgian recommendations for managing psoriasis in a changing treatment landscape

R Speeckaert iD, A F Nikkels, J Lambert iD, F Benhadou, V Reynaert iD, P D Ghislain, T Hillary iD, J L W Lambert

Journal of the European Academy of Dermatology and Venereology · 2025

DOI: 10.1111/jdv.20367 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2025. Verfasst von R Speeckaert und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Ghent University Hospital, Ghent, Belgium. Hauptthemen laut MEDLINE: Biological Products, Dermatologic Agents, Psoriasis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Royal Belgian Society of Dermatology and Venereology, Koninklijke Belgische Vereniging voor Dermatologie en Venerologie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted biologic drugs and small molecules have transformed the psoriasis treatment landscape in recent years. The Belgian healthcare system, in common with many others across Europe, must balance the burgeoning use of these transformative, yet expensive, drugs with the sustainable use of limited resources. Drawing on recent updates to the EuroGuiDerm and the German S2 psoriasis guidelines, eight Belgian dermatologists experienced in treating patients with psoriasis undertook a quasi‐Delphi initiative to provide perspectives on the current opportunities and challenges in psoriasis. This update focuses on responsible ways to rationalize the use of innovative treatments (e.g. biologics and small molecules). Inherently, this required viewpoints on the International Psoriasis Council's new definition of severe psoriasis, defining psoriasis severity and the concept of treating to target. It discusses the appropriateness of using older biologics classes, biosimilars and personalized dosing and lastly, how teledermatology may play a role in providing sustainable, patient‐centric psoriasis care. In addition, this manuscript includes the updated Belgian evidence‐based treatment advice in psoriasis (BETA‐PSO) to reflect recent data and drug approvals. The recommendations reflect the best practices for clinicians when using systemic and biologic therapies to treat patients with psoriasis and offer guidance on how they may prescribe these drugs sustainably and efficiently.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsDermatologic AgentsPsoriasisHumansBelgiumEvidence-Based MedicineDermatology

Substanzen

Biological ProductsDermatologic Agents

Autor:innen und Institutionen

  • Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
  • Department of Dermatology, Centre Hospitalier Universitaire de Liège, Liège, Belgium.
  • Department of Dermatology, University Hospital of Antwerp, Antwerp, Belgium.
  • Department of Dermatology, Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Department of Dermatology, SKIN Research Group, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
  • Department of Dermatology, Cliniques Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.

ORCID-Profile: R Speeckaert, J Lambert, V Reynaert, T Hillary

Förderung

  • Royal Belgian Society of Dermatology and Venereology
  • Koninklijke Belgische Vereniging voor Dermatologie en Venerologie

Zitieren

APA

Speeckaert, R., Nikkels, A. F., Lambert, J., Benhadou, F., Reynaert, V., Ghislain, P. D., Hillary, T., & Lambert, J. L. W. (2025). Belgian recommendations for managing psoriasis in a changing treatment landscape. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.20367

Vancouver

Speeckaert R, Nikkels AF, Lambert J, Benhadou F, Reynaert V, Ghislain PD, et al. Belgian recommendations for managing psoriasis in a changing treatment landscape. Journal of the European Academy of Dermatology and Venereology. 2025. doi:10.1111/jdv.20367

BibTeX
@article{Speeckaert2025,
  author = {Speeckaert, R and Nikkels, A F and Lambert, J and Benhadou, F and Reynaert, V and Ghislain, P D and Hillary, T and Lambert, J L W},
  title = {Belgian recommendations for managing psoriasis in a changing treatment landscape},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2025},
  doi = {10.1111/jdv.20367}
}
Kostenlos starten →